The outcomes of chemotherapy for light chain amyloidosis(AL amyloidosis): Retrospective analysis

The outcomes of chemotherapy for light chain amyloidosis(AL amyloidosis): Retrospective analysis - The outcomes of chemotherapy for light chain amyloidosis(AL amyloidosis): Retrospective analysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029806

Enrollment

Registered

2017-11-02

Start date

2017-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AL amyloidosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria for this study: (1) diagnosis of AL amyloidosis between January 2008 and December 2016 (2) ages >= 16

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Overall survival rate	—

Secondary

Measure	Time frame
Response rate Relapse rate Adverse event Event-free survival Time to next treatment	—

Countries

Japan

Contacts

Public ContactYusuke Takeda

Chiba University Hospital Department of Hematology

take-you@hospital.chiba-u.jp043-222-7171

Outcome results